Abiopharma

News list

GUGGENHIME ANDREW 🟡 adjusted position in 0 shares of Vaxcyte, Inc. (PCVX) Transaction Date: Jan 14, 2026 | Filing ID: 000002

Full text

News bot Jan. 29, 2026, 2:26 p.m.
🔍 GUGGENHIME ANDREW (Executive)

Company: Vaxcyte, Inc. (PCVX)

Report Date: 2026-01-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 61,850
- Total shares sold: 61,850
Detailed Transactions and Holdings:
- Sold 61,850 shares of Common Stock (Direct)
  Date: 2026-01-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 62,459.00 | transaction_form_type: 5 | Footnotes: F1
- Acquired 61,850 shares of Common Stock (Direct)
  Date: 2026-01-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 61,850.00 | transaction_form_type: 5 | Footnotes: F2
Footnotes:
- F1: The reported transaction involves the Reporting Person's transfer of shares to ALG 2025 GRAT HOLDINGS LLC, of which Reporting Person is the sole member and manager.
- F2: Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the sole annuitant and trustee.